Real world experience with MET inhibitors in MET exon 14 skipping mutated non-small cell lung cancer: largest Indian perspective.
Saved in:
| Title: | Real world experience with MET inhibitors in MET exon 14 skipping mutated non-small cell lung cancer: largest Indian perspective. |
|---|---|
| Authors: | Batra U; Medical Oncology, Rajiv Gandhi Cancer Institute and Research Center, Sector-5, Rohini, New Delhi, 110085, India. ullasbatra@gmail.com., Singh AK; Medical Oncology, Tata Memorial Hospital, Mumbai, India., Nathany S; Molecular Hematology & Oncology, Fortis Memorial Research Institute, Gurugram, Haryana, India., Dewan A; Medical Oncology, Rajiv Gandhi Cancer Institute and Research Center, New Delhi, India. abhinavdewan25@gmail.com., Sharma M; Medical Oncology, Rajiv Gandhi Cancer Institute and Research Center, New Delhi, India., Amrith BP; Medical Oncology, Rajiv Gandhi Cancer Institute and Research Center, New Delhi, India., Mehta A; Molecular Diagnostics, Rajiv Gandhi Cancer Institute and Research Center, New Delhi, India., Batra V; SGT Medical College, Gurugram, Haryana, India., Noronha V; Medical Oncology, Tata Memorial Hospital, Mumbai, India., Prabhash K; Medical Oncology, Tata Memorial Hospital, Mumbai, India. |
| Source: | Discover oncology [Discov Oncol] 2025 Mar 08; Vol. 16 (1), pp. 286. Date of Electronic Publication: 2025 Mar 08. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Springer Country of Publication: United States NLM ID: 101775142 Publication Model: Electronic Cited Medium: Internet ISSN: 2730-6011 (Electronic) Linking ISSN: 27306011 NLM ISO Abbreviation: Discov Oncol Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 2730-6011 |
|---|---|
| DOI: | 10.1007/s12672-025-01864-1 |
